Brain Cancer Patient Finds Hope with Emerging New Therapy
Michigan Health News (December 6, 2018). Brain Cancer Patient Finds Hope with Emerging New Therapy. Please find the full article here.
In The News
-
DEC 06 2018
-
-
DEC 05 2018
Cancer therapy shows promise for some brain tumors
The Philadelphia Inquirer (December 5, 2018): Cancer therapy shows promise for some brain tumors. Please find the full article here.
-
-
SEP 20 2018
Experimental drug ‘nothing short of miraculous’ for father of 4 with super-rare brain tumor
Omaha World-Herald (Friday, September 14, 2018): Experimental drug ‘nothing short of miraculous’ for father of 4 with super-rare brain tumor Please find the full article here.
-
-
APR 05 2018
Musella Foundation About ONC201 Clinical Trials in Pediatric and Adult Patients with H3 K27M Glioma
Brain Tumor News Blast Issue 5,656 (Wednesday, April 4, 2018): ONC201 is an experimental, orally bioavailable, first-in-class small molecule with demonstrated antitumor activity in preclinical models of difficult-to-treat solid and liquid tumors without imparting significant toxicity. It is currently investigated for its safety and efficacy in the following clinical trials: 1) ONC-201 for Recurrent Glioblastomas
-
Business Development
© Copyright 2016 Oncoceutics, Inc. All Rights Reserved.